Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Kaufmann, Maxi, Haase, Rocco, Proschmann, Undine, Ziemssen, Tjalf, Akgün, Katja
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256977/
https://ncbi.nlm.nih.gov/pubmed/30524432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02669
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items